3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Vascular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Fibrosarcoma
1
Esophageal Neoplasms
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Astrocytoma
1
Interventions
relugolix
1
enzalutamide
1
Specimen Handling
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Magnetic Resonance Spectroscopy
1
Biopsy
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Proton Therapy
×
30 days
×
Clear all
No trials found.